Lake Bleu Capital
- Company typePrivate
- Founded2020
- HeadquartersHong Kong, Hong Kong SAR China
- Headcount11–50
- GTM typeB2B
- OfferingServices
Lake Bleu Capital firmographics
Firmographics- Name
- Lake Bleu Capital
- Legal name
- Lake Bleu Capital (Hong Kong) Limited
- Website
- https://lakebleu-cap.com/
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Lake Bleu Capital industry classification
Industry- Product category
- Healthcare Asset Management
- NAICS
- Portfolio Management and Investment Advice (52394), Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Private Banking Advisory & Discretionary Portfolio Management (FSABADAD)
- akta.pro secondary industry
- Offshore & International Private Banking (FSAAABAB)
Keywords
Where Lake Bleu Capital is headquartered
LocationHeadquarters
- HQ city
- Hong Kong
- HQ country
- Hong Kong SAR China
- HQ region
- Asia
Offices2 records
Markets served
Lake Bleu Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Asset Management Fees: Lake Bleu Capital generates revenue through asset management fees from managing the Lake Bleu Prime Healthcare Fund and other investment strategies for professional investors including sovereign wealth funds, endowments, foundations, pension funds, and family offices.
Distribution channels1 record
Marketing channels1 record
Lake Bleu Capital product offering
Product offeringCore offering
Lake Bleu Capital is a Hong Kong-based investment management firm that manages the Lake Bleu Prime Healthcare Fund and other investment strategies for professional investors. It invests across public and private equity in the Chinese healthcare, pharmaceutical, and technology innovation sectors with a long-term, mid-to-late-stage focus. The firm holds a Hong Kong SFC Type 9 (asset management) license and serves institutional clients including sovereign wealth funds, endowments, foundations, pension funds, and family offices globally.
Product overview
Lake Bleu Capital operates as a multi-billion dollar asset management platform offering a unified investment management structure. The core offering consists of the Lake Bleu Prime Healthcare Fund (their flagship award-winning fund) complemented by private equity investment services targeting Chinese healthcare companies and multi-strategy public equity management. These services work together under a single healthcare-specialist investment philosophy, providing both liquid (public) and illiquid (private) investment opportunities for professional investors including sovereign wealth funds, endowments, and family offices.
Differentiator
Problem solved
Functional benefit
Brands
- Lake Bleu Prime Healthcare Fund: The flagship hedge fund of Lake Bleu Capital that has won multiple industry awards from HFM AsiaHedge and EurekaHedge.
Products and services
- Lake Bleu Prime Healthcare Fund A flagship healthcare investment fund that invests in high-growth healthcare companies, applying a value-creating strategy with rigorous bottom-up fundamental research. The fund serves professional investors and has won multiple industry awards including the 2020 AsiaHedge '5 Year Award: over 500m'.
- Healthcare Private Equity Investment Services Private equity investments in the Chinese healthcare industry, focusing on flagship innovative companies across biopharmaceuticals, medical devices, and medical services subsectors. Offered to professional investors with a long-term investment horizon.
- Multi-Strategy Public Equity Management Public equity investment strategies managed alongside private equity, with a primary focus on mid-to-late-stage investments in healthcare, pharmaceutical, and technology innovation sectors. Designed for professional investors seeking liquid healthcare investment opportunities.
Quantifiable outcome
- 2020 AsiaHedge '5 Year Award: over 500m' - only winner in that category
Companies that use Lake Bleu Capital
Customer profileNamed customers4 records
Segments1 record
Ideal customer profiles1 record
Lake Bleu Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Lake Bleu Capital partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Asia Investor Group on Climate Change (AIGCC)strategicLake Bleu Capital officially joined AIGCC on October 17, 2022. AIGCC is an initiative focusing on climate change and net-zero investing issues with over 60 members managing combined AUM greater than $36 trillion. Lake Bleu Capital participates in relevant AIGCC activities and exchanges ideas and best practices with other institutional investors.
Scale indicators2 records
Recent moves4 records
Expansion highlights5 records
Lake Bleu Capital competitors and assessment
Company assessmentBroad incumbents
- Boyu Capital: Hong Kong and China-focused private equity firm managing long-term capital from Asian SWFs and family offices. Comparable as a Hong Kong-domiciled PE platform serving institutional Asian capital with healthcare exposure.
- Primavera Capital: Hong Kong-based alternative investment firm focused on China opportunities across PE and growth equity. Comparable as a HK-based institutional asset manager with multi-strategy China exposure.
- FountainVest Partners: Hong Kong-based private equity firm investing in China across consumer, healthcare, and industrials. Comparable as a HK-based PE platform with healthcare exposure and institutional LP base.
- CDH Investments (Hony Capital): Major China-focused alternative investment firm with healthcare, consumer, and industrial investments. Comparable as a large-scale Chinese asset manager serving institutional capital with healthcare vertical exposure.
- Sequoia Capital China (HongShan): China-focused venture and growth equity firm with healthcare and biotech investments. Comparable as a leading China-focused investment platform with healthcare vertical exposure.
- Warburg Pincus Asia: Global PE firm with a substantial Asia healthcare practice (previously invested in China healthcare leaders). Comparable as a global PE platform with significant Asia healthcare investing capability serving institutional LPs.
- Hillhouse Capital (HHLR Capital Management): Major Asia-focused investment firm with significant healthcare and consumer coverage, headquartered in Asia and managing multi-strategy capital. Directly comparable as a Hong Kong/Asia-based large-scale investment platform investing in healthcare and consumer sectors.
- Bain Capital Asia: Global PE firm with dedicated Asia healthcare practice investing in pharma, biotech, and healthcare services across China and Asia. Comparable as an institutional Asia-PE platform with healthcare focus and multi-strategy capability.
Direct peers
- OrbiMed Advisors: Healthcare-focused investment firm with private equity, venture capital, and public equity strategies globally. Most directly comparable specialist healthcare asset manager serving institutional LPs across public and private markets.
- Loyal Valley Innovation Capital (礼来亚洲/LAV): Healthcare-focused Chinese PE/VC firm with both RMB and USD funds investing across biotech, medtech, and healthcare services in China. Closest pure-play healthcare specialist peer in the China market.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Lake Bleu Capital social profiles
Digital presenceLake Bleu Capital compliance and trust
Trust signalCompliance1 record
Lake Bleu Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lake Bleu Capital leadership team
Management profileNumber of profiles
Profiles1 record
Lake Bleu Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lake Bleu Capital M&A and investment
M&A and investmentM&A
Investments34 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lake Bleu Capital
What does Lake Bleu Capital do?
Lake Bleu Capital is a Hong Kong-based investment management firm that manages the Lake Bleu Prime Healthcare Fund and other investment strategies for professional investors. It invests across public and private equity in the Chinese healthcare, pharmaceutical, and technology innovation sectors with a long-term, mid-to-late-stage focus. The firm holds a Hong Kong SFC Type 9 (asset management) license and serves institutional clients including sovereign wealth funds, endowments, foundations, pension funds, and family offices globally.
Is Lake Bleu Capital a public or private company?
Lake Bleu Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Lake Bleu Capital founded?
Lake Bleu Capital was founded in 2020. It employs 11 to 50 people.
Where is Lake Bleu Capital based?
Lake Bleu Capital is headquartered in Hong Kong, Hong Kong SAR China, in the Asia region.
How does Lake Bleu Capital make money?
One revenue line is on record: asset Management Fees.
Who are Lake Bleu Capital's main competitors?
Broad incumbents on record are Boyu Capital, Primavera Capital, FountainVest Partners, CDH Investments (Hony Capital), Sequoia Capital China (HongShan), Warburg Pincus Asia, Hillhouse Capital (HHLR Capital Management) and Bain Capital Asia. Direct peers are OrbiMed Advisors and Loyal Valley Innovation Capital (礼来亚洲/LAV).
Does Lake Bleu Capital have an API?
No public API is recorded for Lake Bleu Capital.
What industry is Lake Bleu Capital in?
Lake Bleu Capital's product category is Healthcare Asset Management. Its primary akta.pro industry code is FSABADAD, Private Banking Advisory & Discretionary Portfolio Management, with a secondary code of FSAAABAB, Offshore & International Private Banking. Its NAICS code is 52394 and its SIC code is 6282.